Skip to main content
Erschienen in: International Urology and Nephrology 10/2017

19.07.2017 | Urology - Original Paper

Evaluation of physical activity in sarcopenic conditions of kidney transplantation recipients

verfasst von: Masaaki Yanishi, Hiroyasu Tsukaguchi, Yutaka Kimura, Yuya Koito, Kenji Yoshida, Maiko Seo, Eri Jino, Motohiko Sugi, Hidefumi Kinoshita, Tadashi Matsuda

Erschienen in: International Urology and Nephrology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Sarcopenia is an involuntary decline in skeletal muscle mass, strength, and function that normally proceed with aging but may develop faster under some chronic disease conditions. In this study, we compared the physical activity between sarcopenia and non-sarcopenia subgroups in kidney transplant recipients.

Methods

Fifty-eight recipients (42 males and 16 females) were enrolled in this study. Mean age of the recipients was 46.6 ± 12.7 years. Mean duration of dialysis was 2.8 ± 4.0 years. Diagnostic criteria for sarcopenia referred to those of the Asia Working Group for Sarcopenia. The physical activity was assessed using the International Physical Activity Questionnaire, and the intensity of physical activity was expressed in metabolic equivalents (MET).

Results

Based on the skeletal muscle mass index (SMI) as well as functional index (HGS, walking speed), the participants were classified into the three subgroups: 12 patients (20.7%) with sarcopenia (Group 1), 25 (43.1%) with presarcopenia (Group 2), and 21 (36.2%) non-sarcopenia (Group 3). Analysis with ANOVA and pairwise comparisons showed that physical activity measured as total MET-min/week was significantly greater in Group 2 (1292 ± 633) than in Group (1484 ± 262). Moreover, physical activity of Group 3 (2461 ± 1339)-min/week was significantly greater than those of Groups 1 and 2.

Conclusions

Our data indicate that physical activity is restricted under presarcopenia and sarcopenia after kidney transplantation. Considering that the recipient age is now increasing, proper management of sarcopenia may become more crucial to improve the kidney survival and lifetime prognosis of the kidney transplant recipients.
Literatur
1.
Zurück zum Zitat Jensen GL (2008) Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 32(6):656–659CrossRefPubMed Jensen GL (2008) Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 32(6):656–659CrossRefPubMed
2.
Zurück zum Zitat Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119(6):526-e9–526-e17CrossRef Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119(6):526-e9–526-e17CrossRef
3.
Zurück zum Zitat Manders RJ, Little JP, Forbes SC, Candow DG (2012) Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia. Nutrients 4(11):1664–1678CrossRefPubMedPubMedCentral Manders RJ, Little JP, Forbes SC, Candow DG (2012) Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia. Nutrients 4(11):1664–1678CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Foley RN, Wang C, Ishani A, Collins AJ, Murray AM (2007) Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol 27(3):279–286CrossRefPubMed Foley RN, Wang C, Ishani A, Collins AJ, Murray AM (2007) Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol 27(3):279–286CrossRefPubMed
5.
6.
Zurück zum Zitat Noori N, Kopple JD, Kovesdy CP et al (2010) Mid-aim muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5(12):2258–2268CrossRefPubMedPubMedCentral Noori N, Kopple JD, Kovesdy CP et al (2010) Mid-aim muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5(12):2258–2268CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Beddhu S, Pappas LM, Ramkumar N, Samore M (2003) Effects of body size and body composition on survival in hemodialysis patient. J Am Soc Nephrol 14(9):2366–2372CrossRefPubMed Beddhu S, Pappas LM, Ramkumar N, Samore M (2003) Effects of body size and body composition on survival in hemodialysis patient. J Am Soc Nephrol 14(9):2366–2372CrossRefPubMed
8.
Zurück zum Zitat Roshanravan B, Robinson-Cohen C, Patel KV et al (2013) Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 24(5):822–830CrossRefPubMedPubMedCentral Roshanravan B, Robinson-Cohen C, Patel KV et al (2013) Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 24(5):822–830CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ozkayar N, Altun B, Halil M et al (2014) Evaluation of sarcopenia in renal transplant recipients. Nephro Urol Mon 6(4):e20055CrossRef Ozkayar N, Altun B, Halil M et al (2014) Evaluation of sarcopenia in renal transplant recipients. Nephro Urol Mon 6(4):e20055CrossRef
10.
Zurück zum Zitat Yanishi M, Kimura Y, Matsuda T et al (2017) Factors associated with the development of sarcopenia in kidney transplant recipients. Transplant Proc 49(2):288–292CrossRefPubMed Yanishi M, Kimura Y, Matsuda T et al (2017) Factors associated with the development of sarcopenia in kidney transplant recipients. Transplant Proc 49(2):288–292CrossRefPubMed
11.
Zurück zum Zitat Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRefPubMed Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRefPubMed
12.
Zurück zum Zitat Murase N, Katsumura T, Ueda C et al (2002) Validity and reliability of Japanese version of International Physical Activity Questionnaire. J Health Welf Stat 49(11):1–9 Murase N, Katsumura T, Ueda C et al (2002) Validity and reliability of Japanese version of International Physical Activity Questionnaire. J Health Welf Stat 49(11):1–9
13.
Zurück zum Zitat Craig CL, Marshall AL, Sjöström M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefPubMed Craig CL, Marshall AL, Sjöström M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRefPubMed
14.
Zurück zum Zitat Matsuo S, Imai E, Horio M et al (2009) Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M et al (2009) Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
15.
16.
Zurück zum Zitat Raguso CA, Kyle U, Kossovsky MP et al (2006) A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clin Nutr 25(4):573–580CrossRefPubMed Raguso CA, Kyle U, Kossovsky MP et al (2006) A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clin Nutr 25(4):573–580CrossRefPubMed
17.
Zurück zum Zitat Mitchell D, Haan MN, Steinberg FM, Visser M (2003) Body composition in the elderly: the influence of nutritional factors and physical activity. J Nutr Health Aging 7(3):130–139PubMed Mitchell D, Haan MN, Steinberg FM, Visser M (2003) Body composition in the elderly: the influence of nutritional factors and physical activity. J Nutr Health Aging 7(3):130–139PubMed
18.
Zurück zum Zitat Robinson-Cohen CL, Duncan GE, Weiss NS et al (2014) Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol 25(2):399–406CrossRefPubMed Robinson-Cohen CL, Duncan GE, Weiss NS et al (2014) Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol 25(2):399–406CrossRefPubMed
19.
Zurück zum Zitat Baria F, Kamimura MA, Aoike DT, Ammirati A, Rocha ML, de Mello MT, Cuppari L (2014) Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrol Dial Transplant 29(4):857–864CrossRefPubMed Baria F, Kamimura MA, Aoike DT, Ammirati A, Rocha ML, de Mello MT, Cuppari L (2014) Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrol Dial Transplant 29(4):857–864CrossRefPubMed
20.
Zurück zum Zitat Greenwood SA, Koufaki P, Mercer TH et al (2015) Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis 65(3):425–434CrossRefPubMed Greenwood SA, Koufaki P, Mercer TH et al (2015) Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis 65(3):425–434CrossRefPubMed
21.
Zurück zum Zitat Han E, Lee YH, Kim G et al (2016) Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008–2011. Metabolism 65:1531–1540CrossRefPubMed Han E, Lee YH, Kim G et al (2016) Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008–2011. Metabolism 65:1531–1540CrossRefPubMed
22.
Zurück zum Zitat Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B (2011) Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol 43(4):1133–1141CrossRefPubMed Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B (2011) Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol 43(4):1133–1141CrossRefPubMed
23.
Zurück zum Zitat Rauramaa R, Halonen P, Vaisanen SB et al (2004) Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six-year randomized, controlled trial. Ann Intern Med 140(12):1007–1014CrossRefPubMed Rauramaa R, Halonen P, Vaisanen SB et al (2004) Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six-year randomized, controlled trial. Ann Intern Med 140(12):1007–1014CrossRefPubMed
24.
Zurück zum Zitat Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S (2003) The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 18(9):1842–1847CrossRefPubMed Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S (2003) The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 18(9):1842–1847CrossRefPubMed
25.
Zurück zum Zitat Kaysen GA, Kotanko P, Zhu F et al (2009) Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr 19(5):357–364CrossRefPubMedPubMedCentral Kaysen GA, Kotanko P, Zhu F et al (2009) Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr 19(5):357–364CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ojo AO (2006) Cardiovascular complications after renal transplantation and their prevention. Transplantation 82(5):603–611CrossRefPubMed Ojo AO (2006) Cardiovascular complications after renal transplantation and their prevention. Transplantation 82(5):603–611CrossRefPubMed
27.
Zurück zum Zitat Xue QL, Bandeen-Roche K, Varadhan R et al (2008) Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging StudyII. J Gerontol A Biol Sci Med Sci 63:984–990CrossRefPubMed Xue QL, Bandeen-Roche K, Varadhan R et al (2008) Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging StudyII. J Gerontol A Biol Sci Med Sci 63:984–990CrossRefPubMed
28.
Zurück zum Zitat Kim JC, Kalantar-Zadeh K, Kopple JD (2013) Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 24(3):337–351CrossRefPubMed Kim JC, Kalantar-Zadeh K, Kopple JD (2013) Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 24(3):337–351CrossRefPubMed
Metadaten
Titel
Evaluation of physical activity in sarcopenic conditions of kidney transplantation recipients
verfasst von
Masaaki Yanishi
Hiroyasu Tsukaguchi
Yutaka Kimura
Yuya Koito
Kenji Yoshida
Maiko Seo
Eri Jino
Motohiko Sugi
Hidefumi Kinoshita
Tadashi Matsuda
Publikationsdatum
19.07.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1661-4

Weitere Artikel der Ausgabe 10/2017

International Urology and Nephrology 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.